| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000948746 |
Resistant |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.014847011 |
Resistant |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.00906806 |
Resistant |
